Metoprolol-induced changes in myocardial (123)I-metaiodobenzylguanidine uptake in Parkinson's disease.
de Milliano
P A
PA
Department of Cardiology, Academic Medical Center Amsterdam and Ziekenhuis Hilversum, Hilversum, Netherlands.
van Eck-Smit
B L
BL
de Groot
A C
AC
Lie
K I
KI
D019797:3-Iodobenzylguanidine / Q000493:pharmacokinetics*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001342:Autonomic Nervous System Diseases / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D006321:Heart / Q000000981:diagnostic imaging* / Q000187:drug effects / Q000294:innervation; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy* / Q000209:etiology; D007457:Iodine Radioisotopes; D008297:Male; D008790:Metoprolol / Q000627:therapeutic use*; D008875:Middle Aged; D009206:Myocardium / Q000378:metabolism*; D010300:Parkinson Disease / Q000150:complications*; D015899:Tomography, Emission-Computed, Single-Photon
D000889:Anti-Arrhythmia Agents; D007457:Iodine Radioisotopes; D019797:3-Iodobenzylguanidine; D008790:Metoprolol